Santiago
Moreno Guillén
Catedrático/a de Universidad
Orlando Immunology Center
Orlando, Estados UnidosPublicaciones en colaboración con investigadores/as de Orlando Immunology Center (1)
2020
-
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
The Lancet HIV, Vol. 7, Núm. 11, pp. e740-e751